Thermo Fisher Scientific Operating Margin 2010-2022 | TMO
Current and historical operating margin for Thermo Fisher Scientific (TMO) over the last 10 years. The current operating profit margin for Thermo Fisher Scientific as of December 31, 2022 is 20.39%.
| Thermo Fisher Scientific Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2022-12-31 |
$44.92B |
$8.39B |
18.69% |
| 2022-09-30 |
$44.17B |
$9.07B |
20.54% |
| 2022-06-30 |
$42.82B |
$9.64B |
22.51% |
| 2022-03-31 |
$41.12B |
$9.80B |
23.83% |
| 2021-12-31 |
$39.21B |
$10.03B |
25.57% |
| 2021-09-30 |
$39.06B |
$10.56B |
27.04% |
| 2021-06-30 |
$38.25B |
$10.71B |
28.00% |
| 2021-03-31 |
$35.89B |
$9.94B |
27.68% |
| 2020-12-31 |
$32.22B |
$7.79B |
24.19% |
| 2020-09-30 |
$28.50B |
$5.96B |
20.90% |
| 2020-06-30 |
$26.25B |
$4.48B |
17.05% |
| 2020-03-31 |
$25.65B |
$4.58B |
17.86% |
| 2019-12-31 |
$25.54B |
$4.59B |
17.99% |
| 2019-09-30 |
$25.22B |
$4.51B |
17.88% |
| 2019-06-30 |
$24.87B |
$4.48B |
18.00% |
| 2019-03-31 |
$24.63B |
$3.92B |
15.90% |
| 2018-12-31 |
$24.36B |
$3.78B |
15.53% |
| 2018-09-30 |
$23.90B |
$3.59B |
15.03% |
| 2018-06-30 |
$23.09B |
$3.31B |
14.35% |
| 2018-03-31 |
$22.01B |
$3.13B |
14.21% |
| 2017-12-31 |
$20.92B |
$2.96B |
14.15% |
| 2017-09-30 |
$19.82B |
$2.76B |
13.94% |
| 2017-06-30 |
$19.20B |
$2.67B |
13.91% |
| 2017-03-31 |
$18.74B |
$2.56B |
13.66% |
| 2016-12-31 |
$18.27B |
$2.46B |
13.45% |
| 2016-09-30 |
$17.97B |
$2.39B |
13.28% |
| 2016-06-30 |
$17.61B |
$2.41B |
13.68% |
| 2016-03-31 |
$17.34B |
$2.37B |
13.65% |
| 2015-12-31 |
$16.97B |
$2.34B |
13.77% |
| 2015-09-30 |
$16.81B |
$2.29B |
13.60% |
| 2015-06-30 |
$16.85B |
$2.36B |
14.01% |
| 2015-03-31 |
$16.91B |
$2.11B |
12.51% |
| 2014-12-31 |
$16.89B |
$2.50B |
14.82% |
| 2014-09-30 |
$15.86B |
$2.32B |
14.62% |
| 2014-06-30 |
$14.89B |
$2.07B |
13.91% |
| 2014-03-31 |
$13.80B |
$2.10B |
15.20% |
| 2013-12-31 |
$13.09B |
$1.61B |
12.29% |
| 2013-09-30 |
$12.88B |
$1.56B |
12.07% |
| 2013-06-30 |
$12.78B |
$1.52B |
11.86% |
| 2013-03-31 |
$12.65B |
$1.51B |
11.93% |
| 2012-12-31 |
$12.51B |
$1.48B |
11.85% |
| 2012-09-30 |
$12.30B |
$1.43B |
11.62% |
| 2012-06-30 |
$12.15B |
$1.39B |
11.47% |
| 2012-03-31 |
$11.90B |
$1.29B |
10.85% |
| 2011-12-31 |
$11.56B |
$1.25B |
10.81% |
| 2011-09-30 |
$11.05B |
$1.21B |
10.90% |
| 2011-06-30 |
$10.75B |
$1.19B |
11.09% |
| 2011-03-31 |
$10.49B |
$1.23B |
11.68% |
| 2010-12-31 |
$10.39B |
$1.19B |
11.44% |
| 2010-09-30 |
$10.49B |
$1.16B |
11.08% |
| 2010-06-30 |
$10.40B |
$1.14B |
10.93% |
| 2010-03-31 |
$10.28B |
$1.10B |
10.67% |
| 2009-12-31 |
$9.91B |
$1.00B |
10.11% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$230.517B |
$44.915B |
|
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
|
